Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04059224
Title TraMel-WT: A Trial of Trametinib in Patients With Advanced Pretreated BRAFV600 Wild-type Melanoma (TraMel-WT)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Universitair Ziekenhuis Brussel
Indications

melanoma

Therapies

Dabrafenib + Trametinib

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST